Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Vibrio cholerae motility exerts drag force to impede attack by the bacterial predator Bdellovibrio bacteriovorus.

Duncan MC, Forbes JC, Nguyen Y, Shull LM, Gillette RK, Lazinski DW, Ali A, Shanks RMQ, Kadouri DE, Camilli A.

Nat Commun. 2018 Nov 12;9(1):4757. doi: 10.1038/s41467-018-07245-3.

2.

Lon Protease Has Multifaceted Biological Functions in Acinetobacter baumannii.

Ching C, Yang B, Onwubueke C, Lazinski D, Camilli A, Godoy VG.

J Bacteriol. 2018 Dec 20;201(2). pii: e00536-18. doi: 10.1128/JB.00536-18. Print 2019 Jan 15.

PMID:
30348832
3.

Growth arrest and a persister state enable resistance to osmotic shock and facilitate dissemination of Vibrio cholerae.

Silva-Valenzuela CA, Lazinski DW, Kahne SC, Nguyen Y, Molina-Quiroz RC, Camilli A.

ISME J. 2017 Dec;11(12):2718-2728. doi: 10.1038/ismej.2017.121. Epub 2017 Jul 25.

4.

High-resolution cone-beam computed tomography for assessment of bone invasion in oral cancer: Comparison with conventional computed tomography.

Czerwonka L, Bissada E, Goldstein DP, Wood RE, Lam EW, Yu E, Lazinski D, Irish JC.

Head Neck. 2017 Oct;39(10):2016-2020. doi: 10.1002/hed.24858. Epub 2017 Jul 12.

PMID:
28703386
5.

A Mutation in the Bacillus subtilis rsbU Gene That Limits RNA Synthesis during Sporulation.

Rothstein DM, Lazinski D, Osburne MS, Sonenshein AL.

J Bacteriol. 2017 Jun 27;199(14). pii: e00212-17. doi: 10.1128/JB.00212-17. Print 2017 Jul 15.

6.

Giant Prolactinoma Presenting As a Base of Skull Tumor With Nasopharyngeal Extension: A Potential Diagnostic Pitfall in Neuroendocrine Lesions of the Base of Skull.

Prawira A, Lazinski D, Siu LL, Perez-Ordonez B.

Head Neck Pathol. 2017 Dec;11(4):537-540. doi: 10.1007/s12105-017-0782-5. Epub 2017 Feb 14.

7.

Immunity Provided by an Outer Membrane Vesicle Cholera Vaccine Is Due to O-Antigen-Specific Antibodies Inhibiting Bacterial Motility.

Wang Z, Lazinski DW, Camilli A.

Infect Immun. 2016 Dec 29;85(1). pii: e00626-16. doi: 10.1128/IAI.00626-16. Print 2017 Jan.

8.

A comparative study of ChIP-seq sequencing library preparation methods.

Sundaram AY, Hughes T, Biondi S, Bolduc N, Bowman SK, Camilli A, Chew YC, Couture C, Farmer A, Jerome JP, Lazinski DW, McUsic A, Peng X, Shazand K, Xu F, Lyle R, Gilfillan GD.

BMC Genomics. 2016 Oct 21;17(1):816.

9.

Transposon-Sequencing Analysis Unveils Novel Genes Involved in the Generation of Persister Cells in Uropathogenic Escherichia coli.

Molina-Quiroz RC, Lazinski DW, Camilli A, Levy SB.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6907-6910. doi: 10.1128/AAC.01617-16. Print 2016 Nov.

10.

Global Tn-seq analysis of carbohydrate utilization and vertebrate infectivity of Borrelia burgdorferi.

Troy EB, Lin T, Gao L, Lazinski DW, Lundt M, Camilli A, Norris SJ, Hu LT.

Mol Microbiol. 2016 Sep;101(6):1003-23. doi: 10.1111/mmi.13437. Epub 2016 Jul 15.

11.

Carbon catabolite repression by seryl phosphorylated HPr is essential to Streptococcus pneumoniae in carbohydrate-rich environments.

Fleming E, Lazinski DW, Camilli A.

Mol Microbiol. 2015 Jul;97(2):360-80. doi: 10.1111/mmi.13033. Epub 2015 May 15.

12.

Genetic basis of persister tolerance to aminoglycosides in Escherichia coli.

Shan Y, Lazinski D, Rowe S, Camilli A, Lewis K.

MBio. 2015 Apr 7;6(2). pii: e00078-15. doi: 10.1128/mBio.00078-15.

13.

Genome-Wide Fitness and Genetic Interactions Determined by Tn-seq, a High-Throughput Massively Parallel Sequencing Method for Microorganisms.

van Opijnen T, Lazinski DW, Camilli A.

Curr Protoc Microbiol. 2015 Feb 2;36:1E.3.1-24. doi: 10.1002/9780471729259.mc01e03s36.

14.

Genes contributing to Staphylococcus aureus fitness in abscess- and infection-related ecologies.

Valentino MD, Foulston L, Sadaka A, Kos VN, Villet RA, Santa Maria J Jr, Lazinski DW, Camilli A, Walker S, Hooper DC, Gilmore MS.

MBio. 2014 Sep 2;5(5):e01729-14. doi: 10.1128/mBio.01729-14.

15.

Genome-Wide Fitness and Genetic Interactions Determined by Tn-seq, a High-Throughput Massively Parallel Sequencing Method for Microorganisms.

van Opijnen T, Lazinski DW, Camilli A.

Curr Protoc Mol Biol. 2014 Apr 14;106:7.16.1-24. doi: 10.1002/0471142727.mb0716s106. Review.

16.

Identification of in vivo regulators of the Vibrio cholerae xds gene using a high-throughput genetic selection.

McDonough E, Lazinski DW, Camilli A.

Mol Microbiol. 2014 Apr;92(2):302-15. doi: 10.1111/mmi.12557. Epub 2014 Mar 14.

17.

Identification of a membrane-bound transcriptional regulator that links chitin and natural competence in Vibrio cholerae.

Dalia AB, Lazinski DW, Camilli A.

MBio. 2014 Jan 28;5(1):e01028-13. doi: 10.1128/mBio.01028-13.

18.

Gene fitness landscapes of Vibrio cholerae at important stages of its life cycle.

Kamp HD, Patimalla-Dipali B, Lazinski DW, Wallace-Gadsden F, Camilli A.

PLoS Pathog. 2013;9(12):e1003800. doi: 10.1371/journal.ppat.1003800. Epub 2013 Dec 26.

19.

A core microbiome associated with the peritoneal tumors of pseudomyxoma peritonei.

Gilbreath JJ, Semino-Mora C, Friedline CJ, Liu H, Bodi KL, McAvoy TJ, Francis J, Nieroda C, Sardi A, Dubois A, Lazinski DW, Camilli A, Testerman TL, Merrell DS.

Orphanet J Rare Dis. 2013 Jul 12;8:105. doi: 10.1186/1750-1172-8-105.

20.

Understanding barriers to Borrelia burgdorferi dissemination during infection using massively parallel sequencing.

Troy EB, Lin T, Gao L, Lazinski DW, Camilli A, Norris SJ, Hu LT.

Infect Immun. 2013 Jul;81(7):2347-57. doi: 10.1128/IAI.00266-13. Epub 2013 Apr 22.

21.

Characterization of undermethylated sites in Vibrio cholerae.

Dalia AB, Lazinski DW, Camilli A.

J Bacteriol. 2013 May;195(10):2389-99. doi: 10.1128/JB.02112-12. Epub 2013 Mar 15.

22.

A bacteriophage encodes its own CRISPR/Cas adaptive response to evade host innate immunity.

Seed KD, Lazinski DW, Calderwood SB, Camilli A.

Nature. 2013 Feb 28;494(7438):489-91. doi: 10.1038/nature11927.

23.

Genotyping 1000 yeast strains by next-generation sequencing.

Wilkening S, Tekkedil MM, Lin G, Fritsch ES, Wei W, Gagneur J, Lazinski DW, Camilli A, Steinmetz LM.

BMC Genomics. 2013 Feb 9;14:90. doi: 10.1186/1471-2164-14-90.

24.
25.

Identification of essential genes of the periodontal pathogen Porphyromonas gingivalis.

Klein BA, Tenorio EL, Lazinski DW, Camilli A, Duncan MJ, Hu LT.

BMC Genomics. 2012 Oct 31;13:578. doi: 10.1186/1471-2164-13-578.

26.

Chondromyxoid fibroma of the skull base: case report and review of the literature.

Yu E, Vescan A, Perez-Ordonez B, Lazinski D, Bartlett E.

J Otolaryngol Head Neck Surg. 2009 Oct;38(5):E114-7. Review. No abstract available.

PMID:
19769816
27.

Magnetic resonance imaging evidence of progression of subacute brain atrophy in moderate to severe traumatic brain injury.

Ng K, Mikulis DJ, Glazer J, Kabani N, Till C, Greenberg G, Thompson A, Lazinski D, Agid R, Colella B, Green RE.

Arch Phys Med Rehabil. 2008 Dec;89(12 Suppl):S35-44. doi: 10.1016/j.apmr.2008.07.006.

PMID:
19081440
28.

The vibrio cholerae hybrid sensor kinase VieS contributes to motility and biofilm regulation by altering the cyclic diguanylate level.

Martinez-Wilson HF, Tamayo R, Tischler AD, Lazinski DW, Camilli A.

J Bacteriol. 2008 Oct;190(19):6439-47. doi: 10.1128/JB.00541-08. Epub 2008 Aug 1.

29.

Large subcutaneous fluid collection attributed to suspected epidural catheter leak.

Whitty RJ, Lazinski D, Carvalho JC.

Anesth Analg. 2007 Jan;104(1):230-1. No abstract available.

PMID:
17179301
30.
31.
32.

Genetic and biochemical strategies to elucidate the architecture and targets of a processive transcription antiterminator from bacteriophage lambda.

Das A, Garcia Mena J, Jana N, Lazinski D, Michaud G, Sengupta S, Zhang Z.

Methods Enzymol. 2003;371:438-59. No abstract available.

PMID:
14712720
33.
34.
35.

Replicating hepatitis delta virus RNA is edited in the nucleus by the small form of ADAR1.

Wong SK, Lazinski DW.

Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):15118-23. Epub 2002 Oct 24.

37.

Hepatitis delta virus minimal substrates competent for editing by ADAR1 and ADAR2.

Sato S, Wong SK, Lazinski DW.

J Virol. 2001 Sep;75(18):8547-55.

38.

Substrate recognition by ADAR1 and ADAR2.

Wong SK, Sato S, Lazinski DW.

RNA. 2001 Jun;7(6):846-58.

39.

Dissecting aneurysms of the posterior cerebral artery: angioarchitecture and a review of the literature.

Lazinski D, Willinsky RA, TerBrugge K, Montanera W.

Neuroradiology. 2000 Feb;42(2):128-33. Review.

PMID:
10663491
40.

A host-specific function is required for ligation of a wide variety of ribozyme-processed RNAs.

Reid CE, Lazinski DW.

Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):424-9.

42.

Regulation of the hepatitis delta virus ribozymes: to cleave or not to cleave?

Lazinski DW, Taylor JM.

RNA. 1995 May;1(3):225-33. Review. No abstract available.

45.

Recent developments in hepatitis delta virus research.

Lazinski DW, Taylor JM.

Adv Virus Res. 1994;43:187-231. Review. No abstract available.

PMID:
8191954
46.

RNA editing in the replication cycle of human hepatitis delta virus.

Wu TT, Netter HJ, Bichko V, Lazinski D, Taylor J.

Biochimie. 1994;76(12):1205-8. Review.

PMID:
7748955
47.

Relating structure to function in the hepatitis delta virus antigen.

Lazinski DW, Taylor JM.

J Virol. 1993 May;67(5):2672-80.

48.

Modified HDV as a vector for the delivery of biologically-active RNAs.

Netter HJ, Hsieh SY, Lazinski D, Taylor J.

Prog Clin Biol Res. 1993;382:373-6. No abstract available.

PMID:
8502706
49.

Structure and function of the delta virus antigens.

Lazinski DW, Taylor JM.

Prog Clin Biol Res. 1993;382:35-44. No abstract available.

PMID:
8502702
50.

Editing on the genomic RNA of human hepatitis delta virus.

Zheng H, Fu TB, Lazinski D, Taylor J.

J Virol. 1992 Aug;66(8):4693-7.

Supplemental Content

Loading ...
Support Center